The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Bortezomib · BORTEZOMIB 3.5 mg/1.4mL · Injection · Intravenous; Subcutaneous · Shilpa Medicare Limited
NDC 63759-3032-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 1.4 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | BORTEZOMIB 3.5 mg/1.4mL | Jul 15, 2026 | Sep 2, 2026 |
| MAIA Pharmaceuticals, Inc. | BORTEZOMIB 1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| MAIA Pharmaceuticals, Inc. | BORTEZOMIB 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Shilpa Medicare Limited | BORTEZOMIB 3.5 mg/1.4mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Bortezomib — NDC 63759-3032-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63759303201.
Free to cite with attribution — see how the data is put together.